Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aterian Inc (ATER) vs Macy's Inc (M) Price & Performance

Aterian IncTrade
Macy's IncTrade

Price performance (Past 24H)

Key statistics

Aterian Inc vs Macy's Inc — how do they compare? Aterian Inc trades at $1.28 (market cap $12.98M), while Macy's Inc trades at $23.8 (market cap $6.11B). The key difference: Macy's Inc is far larger — about 470.7× Aterian Inc's market cap, and Macy's Inc pays a 3.3% dividend while Aterian Inc pays none. Which is the better fit depends on your goals.

ATERM
Market Cap
$12.98M$6.11B
Sector
Consumer CyclicalConsumer Cyclical
52-Week High
$1.39$25.96
52-Week Low
$0.54$11.90
Enterprise Value
$13.56M$9.92B
Dividend Yield
3.3%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aterian Inc

Aterian (ATER) trades at $1.19, up 3.48% with a bullish technical signal despite negative profitability. Recent earnings beats and a pending asset sale that could return $0.85-$1.14 per share provide near-term catalysts. However, the company shows declining revenue from $221M in 2022 to $69M in 2025, with negative net income margins and cash flow challenges.

The outlook hinges on shareholder approval of the brand portfolio sale, offering potential shareholder returns near current price levels. Investment opportunity exists in the asset sale catalyst, but risks include ongoing operational losses, declining revenue, and negative cash flow. Analyst sentiment is evenly split between Buy and Hold recommendations.

Macy's Inc

Macy's (M) trades at $22.78, up 0.62% on the day, with a neutral technical signal. The stock shows attractive valuation metrics, including a P/E of 9.41 and P/S of 0.28, alongside improving cash flow and a recent earnings beat streak. The 'Bold New Chapter' strategy is driving operational improvements, with Berkshire Hathaway's new stake in Q1 2026 signaling institutional confidence.

The outlook is cautiously optimistic, supported by low valuation and strategic initiatives, but risks include margin pressure from retail sector headwinds and execution challenges in the turnaround plan. Analyst consensus is mixed, with a $24.83 price target suggesting modest upside potential from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aterian Inc

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Read more on ATER

About Macy's Inc

Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.

Read more on M